These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 27117535)

  • 21. Thirty-four patients with carcinoma of the cervical esophagus treated with chemoradiation therapy.
    Burmeister BH; Dickie G; Smithers BM; Hodge R; Morton K
    Arch Otolaryngol Head Neck Surg; 2000 Feb; 126(2):205-8. PubMed ID: 10680872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes from chemoradiotherapy for patients with esophageal cancer.
    Pantling AZ; Gossage JA; Mamidanna R; Newman G; Robinson A; Manifold DK; Hale PC
    Dis Esophagus; 2011 Apr; 24(3):172-6. PubMed ID: 21073614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The value of the combination of hemoglobin, albumin, lymphocyte and platelet in predicting platinum-based chemoradiotherapy response in male patients with esophageal squamous cell carcinoma.
    Cong L; Hu L
    Int Immunopharmacol; 2017 May; 46():75-79. PubMed ID: 28268208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized study of low-dose versus standard-dose chemoradiotherapy for unresectable esophageal squamous cell carcinoma (JCOG0303).
    Shinoda M; Ando N; Kato K; Ishikura S; Kato H; Tsubosa Y; Minashi K; Okabe H; Kimura Y; Kawano T; Kosugi S; Toh Y; Nakamura K; Fukuda H;
    Cancer Sci; 2015 Apr; 106(4):407-12. PubMed ID: 25640628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility and efficiency of concurrent chemoradiotherapy with capecitabine and cisplatin versus radiotherapy alone for elderly patients with locally advanced esophageal squamous cell carcinoma: Experience of two centers.
    Chen F; Luo H; Xing L; Liang N; Xie J; Zhang J
    Thorac Cancer; 2018 Jan; 9(1):59-65. PubMed ID: 29024498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemoradiotherapy for esophageal squamous cell cancer.
    Sasaki Y; Kato K
    Jpn J Clin Oncol; 2016 Sep; 46(9):805-10. PubMed ID: 27380810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concurrent chemoradiotherapy for esophageal cancer with malignant fistula.
    Koike R; Nishimura Y; Nakamatsu K; Kanamori S; Shibata T
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1418-22. PubMed ID: 18234437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy and safety of simultaneous integrated boost intensity-modulated radiation therapy for esophageal squamous cell carcinoma in Chinese population: A single institution experience.
    Xu Y; Wang Z; Liu G; Zheng X; Wang Y; Feng W; Lai X; Zhou X; Li P; Ma H; Wang J; Hu X; Chen M
    J Cancer Res Ther; 2016 Oct; 12(Supplement):82-88. PubMed ID: 27721262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The current status of multimodality treatment for unresectable locally advanced esophageal squamous cell carcinoma.
    Hirano H; Boku N
    Asia Pac J Clin Oncol; 2018 Aug; 14(4):291-299. PubMed ID: 29873183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes and prognostic factors for patients with cervical esophageal cancer undergoing definitive radiotherapy or chemoradiotherapy.
    Du XX; Yu R; Wang ZF; Du DC; Liu QY; Wang RM; Kang SR; Yang H
    Bosn J Basic Med Sci; 2019 May; 19(2):186-194. PubMed ID: 30877837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective trial of concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil and cisplatin for T4 esophageal cancer with or without fistula.
    Nishimura Y; Suzuki M; Nakamatsu K; Kanamori S; Yagyu Y; Shigeoka H
    Int J Radiat Oncol Biol Phys; 2002 May; 53(1):134-9. PubMed ID: 12007951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).
    Ishida K; Ando N; Yamamoto S; Ide H; Shinoda M
    Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Definite intensity-modulated radiotherapy with concurrent chemotherapy more than 4 cycles improved survival for patients with locally-advanced or inoperable esophageal squamous cell carcinoma.
    Hsieh HY; Hsu CP; Yeh HL; Chuang CY; Lin JF; Chang CF
    Kaohsiung J Med Sci; 2018 May; 34(5):281-289. PubMed ID: 29699635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes for Esophageal Squamous Cell Carcinoma Treated with Curative Intent in a Western Cohort: Should Multimodal Therapy Be the Gold Standard?
    Sheil F; Donohoe CL; King S; O'Toole D; Cunningham M; Cuffe S; Ravi N; Reynolds JV
    World J Surg; 2018 May; 42(5):1485-1495. PubMed ID: 29075858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment results of preoperative concurrent chemoradiotherapy followed by surgery for stage III or IV esophageal squamous cell carcinoma.
    Yamashita H; Nakagawa K; Tago M; Nakamura N; Shiraishi K; Mafune K; Kaminishi M; Ohtomo K
    Radiat Med; 2006 Jan; 24(1):65-71. PubMed ID: 16715664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overall Survival of Patients with Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma Treated with Nimotuzumab in the Real World.
    Saumell Y; Sanchez L; González S; Ortiz R; Medina E; Galán Y; Lage A
    Adv Ther; 2017 Dec; 34(12):2638-2647. PubMed ID: 29134427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of failure and clinical outcomes of definitive radiotherapy for cervical esophageal cancer.
    Zhao L; Zhou Y; Mu Y; Chai G; Xiao F; Tan L; Lin SH; Shi M
    Oncotarget; 2017 Mar; 8(13):21852-21860. PubMed ID: 28423530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma.
    Murakami M; Kuroda Y; Okamoto Y; Kono K; Yoden E; Kusumi F; Hajiro K; Matsusue S; Takeda H
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1049-59. PubMed ID: 9539559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II study of concurrent chemoradiation in combination with erlotinib for locally advanced esophageal carcinoma.
    Li G; Hu W; Wang J; Deng X; Zhang P; Zhang X; Xie C; Wu S
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1407-12. PubMed ID: 20350790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concurrent chemoradiotherapy or endoscopic stenting for advanced squamous cell carcinoma of esophagus: a case-control study.
    Wong SK; Chiu PW; Leung SF; Cheung KY; Chan AC; Au-Yeung AC; Griffith JF; Chung SS; Ng EK
    Ann Surg Oncol; 2008 Feb; 15(2):576-82. PubMed ID: 18057993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.